STRO – sutro biopharma, inc. (US:NASDAQ)
Stock Stats
News
Sutro Biopharma (STRO) was upgraded by Truist Financial Corporation to "strong-buy".
Sutro Biopharma (STRO) had its price target raised by Deutsche Bank Aktiengesellschaft from $51.00 to $55.00. They now have a "buy" rating on the stock.
Sutro Biopharma (STRO) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $27.00 price target on the stock, up from $8.00.
Sutro Biopharma (STRO) was upgraded by HC Wainwright from "neutral" to "buy". They now have a $28.00 price target on the stock, up from $10.00.
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]
Form S-3 SUTRO BIOPHARMA, INC.
Form S-8 SUTRO BIOPHARMA, INC.
Form 10-K SUTRO BIOPHARMA, INC. For: Dec 31
Form 8-K SUTRO BIOPHARMA, INC. For: Mar 23
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: Pauling David
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.